EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: A report of literature and current practice review

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3108166 39 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: A report of literature and current practice review
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
The European Association for Cardiovascular Imaging (EACVI) has outlined the rationale for setting appropriate use criteria (AUC) in cardiovascular (CV) imaging. Transthoracic echocardiography (TTE) is the most common imaging modality in CV disease and is a central tool in diagnosis, follow-up, management planning and intervention. The purpose of AUC is to inform referrers, both to avoid under-use, which may result in incomplete or incorrect diagnosis and treatment, and also over-use, which may delay correct diagnosis, lead to 'treatment cascade', and wastes resources. The first step in defining AUC for TTE in the adult has been for a panel of experts in echocardiography to review the evidence, guidelines, recommendations, and position papers from the European Society of Cardiology, EACVI and other specialist societies, and current state-of-the-art clinical practice. The attached document summarizes this work, which will be used to under-pin the development of AUC. © The Author 2017.
Έτος δημοσίευσης:
2017
Συγγραφείς:
Steeds, R.P.
Garbi, M.
Cardim, N.
Kasprzak, J.D.
Sade, E.
Nihoyannopoulos, P.
Popescu, B.A.
Stefanidis, A.
Cosyns, B.
Monaghan, M.
Aakhus, S.
Edvardsen, T.
Flachskampf, F.
Galiuto, L.
Athanassopoulos, G.
Lancellotti, P.
Delgado, V.
Donal, E.
Galderisi, M.
Lombardi, M.
Muraru, D.
Haugaa, K.
EACVI Scientific Documents Committee
Περιοδικό:
European Heart Journal - Cardiovascular Imaging
Εκδότης:
Oxford University Press
Τόμος:
18
Αριθμός / τεύχος:
11
Σελίδες:
1191-1204
Λέξεις-κλειδιά:
natriuretic factor; troponin, acute aortic syndrome; acute coronary syndrome; acute heart failure; adult; aortic disease; aortic regurgitation; aortic stenosis; aortic valve disease; appropriate use criteria; Article; asymptomatic disease; bacterial endocarditis; bicuspid aortopathy; cardiac imaging; cardiac resynchronization therapy; cardiotoxicity; cardiovascular risk; chemoembolization; chronic disease; clinical assessment; clinical practice; congenital heart disease; congestive cardiomyopathy; constrictive pericarditis; device therapy; diabetes mellitus; disease classification; dyslipidemia; dyspnea; embolism; emergency care; emergency surgery; faintness; follow up; genetic predisposition; heart arrest; heart arrhythmia; heart failure; heart muscle revascularization; heart pacing; heart palpitation; heart right ventricle dysplasia; heart surgery; heart transplantation; heart tumor; human; hypertension; hypertrophic cardiomyopathy; ischemic heart disease; lung embolism; medical society; medical specialist; mitral valve regurgitation; mitral valve stenosis; patient risk; pericardial disease; pericardial effusion; pericarditis; practice guideline; pregnancy; priority journal; program appropriateness; pulmonary hypertension; pulmonary vascular disease; restrictive cardiomyopathy; risk assessment; risk factor; screening test; stable angina pectoris; thorax injury; thorax pain; thorax radiography; transcatheter aortic valve implantation; transthoracic echocardiography; treatment indication; tricuspid valve disease; valvular heart disease; cardiovascular disease; diagnostic imaging; echocardiography; Europe; health service; protocol compliance; standards; utilization, Adult; Cardiovascular Diseases; Echocardiography; Europe; Guideline Adherence; Health Services Misuse; Humans
Επίσημο URL (Εκδότης):
DOI:
10.1093/ehjci/jew333
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.